Dale Todd

Citadel Advisors LLC is a SEC-registered investment advisor and hedge fund manager headquartered in Miami, Florida. The firm was founded in 1990 by Kenneth Griffin and is wholly-owned by Citadel Advisors Holdings LP, ultimately held by GFH HFEVA LLC. Citadel Advisors manages private investment funds that are offered exclusively to sophisticated investors.

Sandler Capital Management (Sandler Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. Founded in 1986, Sandler Capital manages both hedge funds and private equity funds for high-net-worth individuals, large family offices, pension funds, asset managers, and other institutions.

Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology.

Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO.

Second Heart Assist, Inc. develops minimally invasive circulatory support platform based on proprietary aortic stent pump technology. The firm's product will be a catheter-based temporary assist pump to treat patients with acute decompensated heart failure and to provide circulatory support to those undergoing percutaneous coronary intervention (PCI). The company was founded by Leslie Miller, Howard J. Leonhardt and Jeff Donofrio in 2015 and is headquartered in Santa Monica, CA.

Stem Cell Bra is an American company that is currently in the pre-clinical testing stage of developing a bra that uses stem cells from a woman's own fat tissue and bone marrow to possibly increase breast size by one cup over a period of 12 weeks. The stem cell bra has shown promising results in a pilot feasibility clinical study conducted in Spain in 2021, with 1/3 of the enrollees experiencing a one cup size increase, 1/3 experiencing a 10% increase, and 1/3 experiencing no change. The company has gathered safety data on 15 sheep and cows with excellent results, showing an increase in breast fullness volume ranging from 20 to 30% and true new breast tissue formation. The company has over 150 USPTO patent and patent pending claims on bioelectric regeneration methods and devices. However, the company cautions that the product is only available in countries where clinical studies have been approved by regulatory authorities and is not yet proven safe or effective in statistically significant controlled clinical studies. The company was founded by Howard J. Leonhardt, who has been the CEO since incorporation.